Administrative Director – Clinical Trials Office
Perlmutter Cancer Center, NYU Langone Health
The Administrative Director is responsible and accountable to ensure multidisciplinary coordination of all clinical research efforts as it relates to the services of the Clinical Trials Office (CTO) and the detailed operational planning, implementing, directing, and coordinating clinical research activities. The Administrative Director oversees clinical research functions of the CTO including but not limited to development, conduct, quality assurance, monitoring, data management, and regulatory compliance for clinical trials. In collaboration with clinical research leadership, provides leadership and oversight of research nurses, clinical research coordinators, data management, regulatory affairs, and quality assurance of the CTO and is responsible for the overall efficient and effective fiscal management and functionality within the policies and guidelines of university, local, state, and federal agencies. We are seeking a candidate with a strong cross-functional coordination skills and the capacity to mentor senior managers who lead a diverse and dynamic staff of over 100 employees.
The position supports the development of an effective administrative, operational and financial infrastructure for clinical trials at PCC network sites, working with leadership from all sites, and oversees the development of NCI sponsored clinical trials including those within the cooperative groups and Cancer Therapy Evaluation Program (CTEP). In conjunction with the Medical Director, Arjun Balar, MD the position is responsible and accountable for preparing all relevant clinical research components of the Cancer Center Support Grant (CCSG) annual non-competing renewal and competitive renewal to the NCI.
Since 2015 the CTO has nearly tripled its staff, leading to a major increase in trial openings and accruals and a marked decrease in time to trial opening. The Phase I unit has also seen yearly increases in accrual, trial complexity and novelty since that time. In line with these improvements, PCC is a member of the GSK Oncology Clinical and Translational Consortium (GSK-OCTC) and became an Early Drug Development Opportunity Program (EDDOP) member within the CTEP Early Therapeutic Clinical Trials Network (ETCTN) High Performance Site Initiative. PCC is also a recent recipient of an NCI CATCH-UP 2020 supplement to increase access to clinical trials for underserved populations under newly appointed Associate Director for Clinical Research, Janice Mehnert, MD.
The Laura and Isaac Perlmutter Cancer Center (PCC) is an NCI-designated university-based, matrix comprehensive cancer center that oversees and directs all cancer research and care in the NYU Langone Health system (NYULH) and affiliated units within New York University (NYU). PCC is the major health care provider to lower Manhattan, and has expanded into Brooklyn, the largest and fastest growing borough in New York City, as well as to Queens and Long Island. NYU engages patients in distinct hospital settings, including two university hospitals, (Tisch/Kimmel and Winthrop), a New York City-funded safety net hospital (Bellevue Hospital Center), a former community hospital in Brooklyn and the VA in Manhattan.
For more information about this opportunity, please contact firstname.lastname@example.org